Assignee
CASTAIGNE JEAN-PAUL
CA·4 granted patents·4 pending applications·17 citations·filing 2009–2011
Top patents by PatentIndex Score
8 records- 0179US9173891B2Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analogCASTAIGNE JEAN-PAUL·Filed 2010·Granted Nov 3, 2015·6 cites·16 claims
- 0278US8921314B2Conjugates of GLP-1 agonists and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Granted Dec 30, 2014·5 cites·8 claims
- 0377US9161988B2Multimeric peptide conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2010·Granted Oct 20, 2015·6 cites·14 claims
- 0457US9914754B2Conjugates of neurotensin or neurotensin analogs and uses thereofCASTAIGNE JEAN PAUL·Filed 2009·Granted Mar 13, 2018·0 cites·25 claims
- 0557US2011288011A1Peptide therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 0646US2011288009A1Leptin and leptin analog conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 0742US2012277158A1Compositions and methods for the transport of therapeutic agentsCASTAIGNE JEAN-PAUL·Filed 2010·Application pending·0 cites
- 0836US2013280281A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CASTAIGNE JEAN-PAUL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →